Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma

被引：40
|
作者：
Blombery, Piers [1 ,2 ,3 ,4 ]
Birkinshaw, Richard W. [5 ,6 ]
Nguyen, Tamia [1 ,4 ]
Gong, Jia-nan [5 ,6 ]
Thompson, Ella R. [1 ,4 ]
Xu, Zhen [5 ,6 ]
Westerman, David A. [1 ,2 ,3 ,4 ]
Czabotar, Peter E. [5 ,6 ]
Dickinson, Michael [2 ,3 ,4 ]
Huang, David C. S. [5 ,6 ]
Seymour, John F. [2 ,3 ,4 ]
Roberts, Andrew W. [2 ,3 ,5 ,6 ,7 ,8 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[5] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia
[7] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia
[8] Victorian Comprehens Canc Ctr, Melbourne, Vic, Australia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 186卷 / 06期
关键词：
BCL2; lymphomas; genetic analysis;
D O I：
10.1111/bjh.16069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E188 / E191
页数：4
相关论文
共 23 条
  • [1] Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation
    van den Brand, Michiel
    Garcia-Garcia, Mar
    Mathijssen, Janneke J. M.
    Colomo, Lluis
    Groenen, Patricia J. T. A.
    Serrano, Sergio
    van Krieken, J. Han J. M.
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (02) : 148 - 150
  • [2] Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
    Xiang Zhang
    Jiejing Qian
    Huafeng Wang
    Yungui Wang
    Yi Zhang
    Pengxu Qian
    Yinjun Lou
    Jie Jin
    Honghu Zhu
    Biomarker Research, 9
  • [3] Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
    Zhang, Xiang
    Qian, Jiejing
    Wang, Huafeng
    Wang, Yungui
    Zhang, Yi
    Qian, Pengxu
    Lou, Yinjun
    Jin, Jie
    Zhu, Honghu
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [4] Development of a Novel Assay for Detection of IGH@ BCL2 Translocation in Follicular Lymphoma
    Harada, S.
    Silzle, E. A.
    Gocke, C. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 918 - 918
  • [5] Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL
    Thangavadivel, Shanmugapriya
    Byrd, John C.
    CANCER DISCOVERY, 2019, 9 (03) : 320 - 322
  • [6] Sonrotoclax overcomes BCL2 G101V mutation - induced venetoclax resistance in preclinical models of hematologic malignancy
    Liu, Jiuyang
    Li, Shuran
    Wang, Qin
    Feng, Yingcai
    Xing, Haimei
    Yang, Xuefei
    Guo, Ying
    Guo, Yunhang
    Sun, Hanzi
    Liu, Xiaoxin
    Yang, Shasha
    Mei, Zhu
    Zhu, Yutong
    Cheng, Zhenzhen
    Chen, Shuaishuai
    Xu, Min
    Zhang, Wenjing
    Wan, Nanyan
    Wang, Jia
    Ma, Yanwen
    Zhang, Shuo
    Luan, Xudong
    Xu, Aiying
    Li, Lin
    Wang, Haitao
    Yang, Xiaolong
    Hong, Yuan
    Xue, Hai
    Yuan, Xi
    Hu, Nan
    Song, Xiaomin
    Wang, Zhiwei
    Liu, Xuesong
    Wang, Lai
    Liu, Ye
    BLOOD, 2024, 143 (18) : 1825 - 1836
  • [7] BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
    Burkhard, Regula
    Bhagat, Govind
    Cogliatti, Sergio B.
    Rossi, Davide
    Gaidano, Gianluca
    Pasqualucci, Laura
    Novak, Urban
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (01) : 23 - 30
  • [8] Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
    Blombery, Piers
    Anderson, Mary Ann
    Gong, Jianan
    Thijssen, Rachel
    Birkinshaw, Richard W.
    Thompson, Ella
    Teh, Charis E.
    Nguyen, Tamia
    Xu, Zhen
    Flensburg, Christoffer
    Lew, Thomas
    Majewski, Ian
    Gray, Daniel
    Westerman, David Alan
    Tam, Constantine S.
    Seymour, John F.
    Czabotar, Peter E.
    Huang, David
    Roberts, Andrew W.
    BLOOD, 2018, 132
  • [9] Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
    Blombery, Piers
    Anderson, Mary Ann
    Gong, Jia-nan
    Thijssen, Rachel
    Birkinshaw, Richard W.
    Thompson, Ella R.
    Teh, Charis E.
    Nguyen, Tamia
    Xu, Zhen
    Flensburg, Christoffer
    Lew, Thomas E.
    Majewski, Ian J.
    Gray, Daniel H. D.
    Westerman, David A.
    Tam, Constantine S.
    Seymour, John F.
    Czabotar, Peter E.
    Huang, David C. S.
    Roberts, Andrew W.
    CANCER DISCOVERY, 2019, 9 (03) : 342 - 353
  • [10] Novel marginal zone lymphoma models of resistance to the dual inhibition of PI3K and BCL2
    Arribas, Alberto J.
    Cascione, Luciano
    Cannas, Eleonora
    Bellerjeau, Helen
    Fuzio, Federica
    Noguera, Aleix
    Rinaldi, Andrea
    Esteller, Manel
    Zucca, Emanuele
    Alimonti, Andrea
    Rossi, Davide
    Stathis, Anastasios
    Bertoni, Francesco
    CANCER RESEARCH, 2024, 84 (06)
123